What is the share price of Dhansa Labs Ltd (DHANSA) today?
The share price of DHANSA as on 18th September 2026 is ₹30.20. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Dhansa Labs Ltd (DHANSA) share?
The past returns of Dhansa Labs Ltd (DHANSA) share are- Past 1 week: -14.93%
- Past 1 month: 40.47%
- Past 3 months: 41.12%
- Past 6 months: 40.14%
- Past 1 year: -27.23%
- Past 3 years: N/A%
- Past 5 years: -66.16%
What are the peers or stocks similar to Dhansa Labs Ltd (DHANSA)?
The peers or stocks similar to Dhansa Labs Ltd (DHANSA) include:What is the market cap of Dhansa Labs Ltd (DHANSA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dhansa Labs Ltd (DHANSA) is ₹81.25 Cr as of 18th September 2026.What is the 52 week high and low of Dhansa Labs Ltd (DHANSA) share?
The 52-week high of Dhansa Labs Ltd (DHANSA) is ₹47 and the 52-week low is ₹16.20.What is the PE and PB ratio of Dhansa Labs Ltd (DHANSA) stock?
The P/E (price-to-earnings) ratio of Dhansa Labs Ltd (DHANSA) is 14.69. The P/B (price-to-book) ratio is 0.82.Which sector does Dhansa Labs Ltd (DHANSA) belong to?
Dhansa Labs Ltd (DHANSA) belongs to the Materials sector & Fertilizers & Agro Chemicals sub-sector.How to buy Dhansa Labs Ltd (DHANSA) shares?
You can directly buy Dhansa Labs Ltd (DHANSA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Dhansa Labs Ltd
DHANSA Share Price
NSEDHANSA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
DHANSA Performance & Key Metrics
DHANSA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 0.82 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 24.23 | 3.04 | 1.43% |
DHANSA Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
DHANSA Company Profile
Dhansa Labs Ltd manufactures and distributes agro and home hygiene products including chemicals, compounds, herbal products, insecticides, pesticides, fungicides, and 2,4-D base chemicals such as 2,4-D amine salt and hexaconazole, alongside home hygiene items like phenyle, floor cleaners, toilet cleaners, moth repellents, hand wash, and sanitizers.
DHANSA Forecast
DHANSA Forecasts
DHANSA
DHANSA
Income
Balance Sheet
Cash Flow
DHANSA Income Statement
DHANSA Income Statement
| Quarter | dec 2025 | mar 2026 | jun 2026 | |||
|---|---|---|---|---|---|---|
| Total Revenue | 33.12 | 41.41 | 30.60 | |||
| Operating & Other expenses | 30.25 | 38.09 | 27.92 | |||
| EBITDA | 2.87 | 3.32 | 2.68 | |||
| Depreciation/Amortization | 0.55 | 0.54 | 0.44 | |||
| PBIT | 2.32 | 2.78 | 2.24 | |||
| Interest & Other Items | 0.32 | 0.38 | 0.71 | |||
| PBT | 2.00 | 2.40 | 1.53 | |||
| Taxes & Other Items | 1.09 | 0.40 | 0.80 | |||
| Net Income | 0.91 | 2.00 | 0.73 | |||
| EPS | 0.36 | 0.80 | 0.28 |
DHANSA Company Updates
DHANSA Stock Peers
DHANSA Past Performance & Peer Comparison
DHANSA Past Performance & Peer Comparison
MaterialsFertilizers & Agro Chemicals
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Dhansa Labs Ltd | 14.69 | 0.82 | — |
| Coromandel International Ltd | 30.10 | 4.48 | 0.10% |
| Fertilisers And Chemicals Travancore Ltd | -1,248.40 | 36.62 | — |
| UPL Limited | 25.50 | 1.19 | 1.03% |
DHANSA Stock Price Comparison
Compare DHANSA with any stock or ETFDHANSA Holdings
DHANSA Shareholdings
DHANSA Promoter Holdings Trend
DHANSA Promoter Holdings Trend
DHANSA Institutional Holdings Trend
DHANSA Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
DHANSA Shareholding Pattern
DHANSA Shareholding Pattern
DHANSA Shareholding History
DHANSA Shareholding History
smallcases containing DHANSA stock
smallcases containing DHANSA stock
Looks like this stock is not in any smallcase yet.
DHANSA Events
DHANSA Events
DHANSA Dividend Trend
DHANSA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
DHANSA Dividend Trend
DHANSA has not given any dividends in last 5 years
DHANSA Dividends
DHANSA Dividends
DHANSA Stock News & Opinions
DHANSA Stock News & Opinions
Net profit of Dhansa Labs rose 78.63% to Rs 2.09 crore in the quarter ended March 2026 as against Rs 1.17 crore during the previous quarter ended March 2025. Sales rose 32.70% to Rs 40.54 crore in the quarter ended March 2026 as against Rs 30.55 crore during the previous quarter ended March 2025. For the full year,net profit rose 19.87% to Rs 5.73 crore in the year ended March 2026 as against Rs 4.78 crore during the previous year ended March 2025. Sales rose 7.82% to Rs 141.54 crore in the year ended March 2026 as against Rs 131.27 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales40.5430.55 33 141.54131.27 8 OPM %5.757.73 -7.717.29 - PBDT3.032.22 36 9.808.58 14 PBT2.491.55 61 7.606.04 26 NP2.091.17 79 5.734.78 20 Powered by Capital Market - Live
Ambey Laboratories will hold a meeting of the Board of Directors of the Company on 29 May 2026.
Ambey Laboratories will hold a meeting of the Board of Directors of the Company on 12 January 2026.Powered by Capital Market - Live
Ambey Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live
Ambey Laboratories announced that the 40th Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live
Ambey Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 26 July 2025.Powered by Capital Market - Live
Ambey Laboratories will hold a meeting of the Board of Directors of the Company on 20 June 2025.Powered by Capital Market - Live
Ambey Laboratories will hold a meeting of the Board of Directors of the Company on 16 May 2025.Powered by Capital Market - Live
Ambey Laboratories will hold a meeting of the Board of Directors of the Company on 30 January 2025.Powered by Capital Market - Live
Ambey Laboratories will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
Pledged promoter holdings is insignificant